For more information and to provide comments, visit https://www.amp.org/opencomment/. The guideline revisions are designed to provide state-of-the-art molecular testing of lung cancer recommendations for pathologists, oncologists, patient advocacy groups, and cancer and molecular diagnostic laboratory professionals. The revisions are all based on evidence
https://www.amp.org/AMP/assets/File/pressreleases/2024/2024_Lung_OCP_PR_FINAL.pd...